Loading…
Protein Domain Specific Covalent Inhibition of Human DNA Polymerase β
DNA polymerase β (Pol β) is a frequently overexpressed and/or mutated bifunctional repair enzyme. Pol β possesses polymerase and lyase active sites, that are employed in two steps of base excision repair. Pol β is an attractive therapeutic target for which there is a need for inhibitors. Two mechani...
Saved in:
Published in: | Chembiochem : a European journal of chemical biology 2021-08, Vol.22 (16), p.2619-2623 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c4687-d6144cafccc9a3235bfad713a4fe653179b91b7ea700a2b7f23c7af62ec4c3643 |
---|---|
cites | cdi_FETCH-LOGICAL-c4687-d6144cafccc9a3235bfad713a4fe653179b91b7ea700a2b7f23c7af62ec4c3643 |
container_end_page | 2623 |
container_issue | 16 |
container_start_page | 2619 |
container_title | Chembiochem : a European journal of chemical biology |
container_volume | 22 |
creator | Yuhas, Shelby C. Majumdar, Ananya Greenberg, Marc M. |
description | DNA polymerase β (Pol β) is a frequently overexpressed and/or mutated bifunctional repair enzyme. Pol β possesses polymerase and lyase active sites, that are employed in two steps of base excision repair. Pol β is an attractive therapeutic target for which there is a need for inhibitors. Two mechanistically inspired covalent inhibitors (1, IC50=21.0 μM; 9, IC50=18.7 μM) that modify lysine residues in different Pol β active sites are characterized. Despite modifying lysine residues in different active sites, 1 and 9 inactivate the polymerase and lyase activities of Pol β. Fluorescence anisotropy experiments indicate that they do so by preventing DNA binding. Inhibitors 1 and 9 provide the basis for a general approach to preparing domain selective inhibitors of bifunctional polymerases. Such molecules could prove to be useful tools for studying the role of wild type and mutant forms of Pol β and other polymerases in DNA repair.
A single synthesis and screening strategy yields covalent inhibitors that inactivate bifunctional DNA polymerase β by modifying lysine residues in different active site domains and prevent DNA binding. |
doi_str_mv | 10.1002/cbic.202100247 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8373715</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2561899132</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4687-d6144cafccc9a3235bfad713a4fe653179b91b7ea700a2b7f23c7af62ec4c3643</originalsourceid><addsrcrecordid>eNqFkctKAzEUhoMoVqtblzLgxk1rbk0mG0HHW0FUUNchkyY2MjOpSUfpa_kgPpMprfWycXUS8uXj_PwA7CHYRxDiI1063ccQzy-Ur4EtRInocUbI-vJMMeYdsB3jM4RQMII2QYdQjEhO2Ba4uAt-alyTnflapXE_MdpZp7PCv6rKNNNs2Ixd6abON5m32VVbqwTfnGR3vprVJqhoso_3HbBhVRXN7nJ2wePF-UNx1bu-vRwWJ9c9TVnOeyOGKNXKaq2FIpgMSqtGHBFFrWEDgrgoBSq5URxChUtuMdFcWYaNppowSrrgeOGdtGVtRjotGFQlJ8HVKsykV07-fmncWD75V5kTTjgaJMHhUhD8S2viVNYualNVqjG-jRIPaE6hQHCOHvxBn30bmhQvUQzlQqAUoQv6C0oHH2MwdrUMgnLeipxXJFcVpQ_7PyOs8K9OEiAWwJurzOwfnSxOh8W3_BPL2p3Q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2561899132</pqid></control><display><type>article</type><title>Protein Domain Specific Covalent Inhibition of Human DNA Polymerase β</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>Yuhas, Shelby C. ; Majumdar, Ananya ; Greenberg, Marc M.</creator><creatorcontrib>Yuhas, Shelby C. ; Majumdar, Ananya ; Greenberg, Marc M.</creatorcontrib><description>DNA polymerase β (Pol β) is a frequently overexpressed and/or mutated bifunctional repair enzyme. Pol β possesses polymerase and lyase active sites, that are employed in two steps of base excision repair. Pol β is an attractive therapeutic target for which there is a need for inhibitors. Two mechanistically inspired covalent inhibitors (1, IC50=21.0 μM; 9, IC50=18.7 μM) that modify lysine residues in different Pol β active sites are characterized. Despite modifying lysine residues in different active sites, 1 and 9 inactivate the polymerase and lyase activities of Pol β. Fluorescence anisotropy experiments indicate that they do so by preventing DNA binding. Inhibitors 1 and 9 provide the basis for a general approach to preparing domain selective inhibitors of bifunctional polymerases. Such molecules could prove to be useful tools for studying the role of wild type and mutant forms of Pol β and other polymerases in DNA repair.
A single synthesis and screening strategy yields covalent inhibitors that inactivate bifunctional DNA polymerase β by modifying lysine residues in different active site domains and prevent DNA binding.</description><identifier>ISSN: 1439-4227</identifier><identifier>ISSN: 1439-7633</identifier><identifier>EISSN: 1439-7633</identifier><identifier>DOI: 10.1002/cbic.202100247</identifier><identifier>PMID: 34213836</identifier><language>eng</language><publisher>Germany: Wiley Subscription Services, Inc</publisher><subject>Anisotropy ; Base excision repair ; Catalytic Domain ; Communication ; Communications ; covalent inhibitors ; Deoxyribonucleic acid ; DNA ; DNA - chemistry ; DNA - metabolism ; DNA damage ; DNA polymerase ; DNA Polymerase beta - antagonists & inhibitors ; DNA Polymerase beta - chemistry ; DNA Polymerase beta - metabolism ; DNA polymerases ; DNA repair ; DNA-directed DNA polymerase ; enzyme inhibition ; Enzyme Inhibitors - chemistry ; Enzyme Inhibitors - pharmacology ; Fluorescence ; Fluorescence Polarization ; Humans ; Inhibitors ; Lysine ; Protein Domains ; Repair ; Residues</subject><ispartof>Chembiochem : a European journal of chemical biology, 2021-08, Vol.22 (16), p.2619-2623</ispartof><rights>2021 The Authors. ChemBioChem published by Wiley-VCH GmbH</rights><rights>2021 The Authors. ChemBioChem published by Wiley-VCH GmbH.</rights><rights>2021. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4687-d6144cafccc9a3235bfad713a4fe653179b91b7ea700a2b7f23c7af62ec4c3643</citedby><cites>FETCH-LOGICAL-c4687-d6144cafccc9a3235bfad713a4fe653179b91b7ea700a2b7f23c7af62ec4c3643</cites><orcidid>0000-0002-5786-6118</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34213836$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yuhas, Shelby C.</creatorcontrib><creatorcontrib>Majumdar, Ananya</creatorcontrib><creatorcontrib>Greenberg, Marc M.</creatorcontrib><title>Protein Domain Specific Covalent Inhibition of Human DNA Polymerase β</title><title>Chembiochem : a European journal of chemical biology</title><addtitle>Chembiochem</addtitle><description>DNA polymerase β (Pol β) is a frequently overexpressed and/or mutated bifunctional repair enzyme. Pol β possesses polymerase and lyase active sites, that are employed in two steps of base excision repair. Pol β is an attractive therapeutic target for which there is a need for inhibitors. Two mechanistically inspired covalent inhibitors (1, IC50=21.0 μM; 9, IC50=18.7 μM) that modify lysine residues in different Pol β active sites are characterized. Despite modifying lysine residues in different active sites, 1 and 9 inactivate the polymerase and lyase activities of Pol β. Fluorescence anisotropy experiments indicate that they do so by preventing DNA binding. Inhibitors 1 and 9 provide the basis for a general approach to preparing domain selective inhibitors of bifunctional polymerases. Such molecules could prove to be useful tools for studying the role of wild type and mutant forms of Pol β and other polymerases in DNA repair.
A single synthesis and screening strategy yields covalent inhibitors that inactivate bifunctional DNA polymerase β by modifying lysine residues in different active site domains and prevent DNA binding.</description><subject>Anisotropy</subject><subject>Base excision repair</subject><subject>Catalytic Domain</subject><subject>Communication</subject><subject>Communications</subject><subject>covalent inhibitors</subject><subject>Deoxyribonucleic acid</subject><subject>DNA</subject><subject>DNA - chemistry</subject><subject>DNA - metabolism</subject><subject>DNA damage</subject><subject>DNA polymerase</subject><subject>DNA Polymerase beta - antagonists & inhibitors</subject><subject>DNA Polymerase beta - chemistry</subject><subject>DNA Polymerase beta - metabolism</subject><subject>DNA polymerases</subject><subject>DNA repair</subject><subject>DNA-directed DNA polymerase</subject><subject>enzyme inhibition</subject><subject>Enzyme Inhibitors - chemistry</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Fluorescence</subject><subject>Fluorescence Polarization</subject><subject>Humans</subject><subject>Inhibitors</subject><subject>Lysine</subject><subject>Protein Domains</subject><subject>Repair</subject><subject>Residues</subject><issn>1439-4227</issn><issn>1439-7633</issn><issn>1439-7633</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><recordid>eNqFkctKAzEUhoMoVqtblzLgxk1rbk0mG0HHW0FUUNchkyY2MjOpSUfpa_kgPpMprfWycXUS8uXj_PwA7CHYRxDiI1063ccQzy-Ur4EtRInocUbI-vJMMeYdsB3jM4RQMII2QYdQjEhO2Ba4uAt-alyTnflapXE_MdpZp7PCv6rKNNNs2Ixd6abON5m32VVbqwTfnGR3vprVJqhoso_3HbBhVRXN7nJ2wePF-UNx1bu-vRwWJ9c9TVnOeyOGKNXKaq2FIpgMSqtGHBFFrWEDgrgoBSq5URxChUtuMdFcWYaNppowSrrgeOGdtGVtRjotGFQlJ8HVKsykV07-fmncWD75V5kTTjgaJMHhUhD8S2viVNYualNVqjG-jRIPaE6hQHCOHvxBn30bmhQvUQzlQqAUoQv6C0oHH2MwdrUMgnLeipxXJFcVpQ_7PyOs8K9OEiAWwJurzOwfnSxOh8W3_BPL2p3Q</recordid><startdate>20210817</startdate><enddate>20210817</enddate><creator>Yuhas, Shelby C.</creator><creator>Majumdar, Ananya</creator><creator>Greenberg, Marc M.</creator><general>Wiley Subscription Services, Inc</general><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QO</scope><scope>7TM</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-5786-6118</orcidid></search><sort><creationdate>20210817</creationdate><title>Protein Domain Specific Covalent Inhibition of Human DNA Polymerase β</title><author>Yuhas, Shelby C. ; Majumdar, Ananya ; Greenberg, Marc M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4687-d6144cafccc9a3235bfad713a4fe653179b91b7ea700a2b7f23c7af62ec4c3643</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Anisotropy</topic><topic>Base excision repair</topic><topic>Catalytic Domain</topic><topic>Communication</topic><topic>Communications</topic><topic>covalent inhibitors</topic><topic>Deoxyribonucleic acid</topic><topic>DNA</topic><topic>DNA - chemistry</topic><topic>DNA - metabolism</topic><topic>DNA damage</topic><topic>DNA polymerase</topic><topic>DNA Polymerase beta - antagonists & inhibitors</topic><topic>DNA Polymerase beta - chemistry</topic><topic>DNA Polymerase beta - metabolism</topic><topic>DNA polymerases</topic><topic>DNA repair</topic><topic>DNA-directed DNA polymerase</topic><topic>enzyme inhibition</topic><topic>Enzyme Inhibitors - chemistry</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Fluorescence</topic><topic>Fluorescence Polarization</topic><topic>Humans</topic><topic>Inhibitors</topic><topic>Lysine</topic><topic>Protein Domains</topic><topic>Repair</topic><topic>Residues</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yuhas, Shelby C.</creatorcontrib><creatorcontrib>Majumdar, Ananya</creatorcontrib><creatorcontrib>Greenberg, Marc M.</creatorcontrib><collection>Wiley Online Library</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Chembiochem : a European journal of chemical biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yuhas, Shelby C.</au><au>Majumdar, Ananya</au><au>Greenberg, Marc M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Protein Domain Specific Covalent Inhibition of Human DNA Polymerase β</atitle><jtitle>Chembiochem : a European journal of chemical biology</jtitle><addtitle>Chembiochem</addtitle><date>2021-08-17</date><risdate>2021</risdate><volume>22</volume><issue>16</issue><spage>2619</spage><epage>2623</epage><pages>2619-2623</pages><issn>1439-4227</issn><issn>1439-7633</issn><eissn>1439-7633</eissn><abstract>DNA polymerase β (Pol β) is a frequently overexpressed and/or mutated bifunctional repair enzyme. Pol β possesses polymerase and lyase active sites, that are employed in two steps of base excision repair. Pol β is an attractive therapeutic target for which there is a need for inhibitors. Two mechanistically inspired covalent inhibitors (1, IC50=21.0 μM; 9, IC50=18.7 μM) that modify lysine residues in different Pol β active sites are characterized. Despite modifying lysine residues in different active sites, 1 and 9 inactivate the polymerase and lyase activities of Pol β. Fluorescence anisotropy experiments indicate that they do so by preventing DNA binding. Inhibitors 1 and 9 provide the basis for a general approach to preparing domain selective inhibitors of bifunctional polymerases. Such molecules could prove to be useful tools for studying the role of wild type and mutant forms of Pol β and other polymerases in DNA repair.
A single synthesis and screening strategy yields covalent inhibitors that inactivate bifunctional DNA polymerase β by modifying lysine residues in different active site domains and prevent DNA binding.</abstract><cop>Germany</cop><pub>Wiley Subscription Services, Inc</pub><pmid>34213836</pmid><doi>10.1002/cbic.202100247</doi><tpages>5</tpages><orcidid>https://orcid.org/0000-0002-5786-6118</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1439-4227 |
ispartof | Chembiochem : a European journal of chemical biology, 2021-08, Vol.22 (16), p.2619-2623 |
issn | 1439-4227 1439-7633 1439-7633 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8373715 |
source | Wiley-Blackwell Read & Publish Collection |
subjects | Anisotropy Base excision repair Catalytic Domain Communication Communications covalent inhibitors Deoxyribonucleic acid DNA DNA - chemistry DNA - metabolism DNA damage DNA polymerase DNA Polymerase beta - antagonists & inhibitors DNA Polymerase beta - chemistry DNA Polymerase beta - metabolism DNA polymerases DNA repair DNA-directed DNA polymerase enzyme inhibition Enzyme Inhibitors - chemistry Enzyme Inhibitors - pharmacology Fluorescence Fluorescence Polarization Humans Inhibitors Lysine Protein Domains Repair Residues |
title | Protein Domain Specific Covalent Inhibition of Human DNA Polymerase β |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-23T23%3A08%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Protein%20Domain%20Specific%20Covalent%20Inhibition%20of%20Human%20DNA%20Polymerase%20%CE%B2&rft.jtitle=Chembiochem%20:%20a%20European%20journal%20of%20chemical%20biology&rft.au=Yuhas,%20Shelby%20C.&rft.date=2021-08-17&rft.volume=22&rft.issue=16&rft.spage=2619&rft.epage=2623&rft.pages=2619-2623&rft.issn=1439-4227&rft.eissn=1439-7633&rft_id=info:doi/10.1002/cbic.202100247&rft_dat=%3Cproquest_pubme%3E2561899132%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4687-d6144cafccc9a3235bfad713a4fe653179b91b7ea700a2b7f23c7af62ec4c3643%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2561899132&rft_id=info:pmid/34213836&rfr_iscdi=true |